ESA Biosciences, Inc. enables answers to pressing applications challenges by applying its expertise in specialty detection and electrochemistry, combined with components, kits, and reagents, for analytical laboratories, commercial diagnostics laboratories, and the clinical point-of-care setting. ESA is a wholly owned subsidiary of Magellan Biosciences, Inc.
About Magellan Biosciences
Magellan serves the worldwide clinical-diagnostics market with rapid
point-of-care analyzers and automated systems for hospital-based labs and
near-patient testing. Scientists use the company's discovery systems and
sensors for cutting-edge research to develop a new understanding of health
and illness -- from disease pathology to biomarker identification. Magellan
designs all its systems, sensors, and consumables to deliver better,
more-reliable results. And better results help drive improved health
outcomes: earlier, more-accurate diagnoses; breakthroughs that can lead to
novel treatments, new cures -- innovations to enhance life. A privately
held company, Magellan serves customers through wholly owned subsidiaries:
ESA Biosciences, Dynex Technologies, and TREK Diagnostic Systems. For more
information, visit http://www.magellanbio.com.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Robb Morse http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=66611
|SOURCE Magellan Biosciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved